Marina Bacac

An Immune Atlas of Clear Cell Renal Cell Carcinoma

Stéphane Chevrier, Jacob Levine, Vito Riccardo Tomaso Zanotelli et al. · Cell · 2017 · 1K citations · Full text

Urology, Cancer Immunosurveillance, Immune Atlas +5

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Martin Hutchings, Franck Morschhauser, Gloria Iacoboni et al. · Journal of Clinical Oncology · 2021 · 392 citations · Full text

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Daniela S. Thommen, Jens Schreiner, Philipp Müller et al. · Cancer Immunology Research · 2015 · 378 citations

Increased Dysfunction, T-regulatory Cell, Immunology +18

Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab <i>In Vitro</i> and in Xenograft Models

Sylvia Herter, Frank Herting, Olaf Mundigl et al. · Molecular Cancer Therapeutics · 2013 · 352 citations

Xenograft Models, Immunology, Immune Regulation +20

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 342 citations · Full text